Company intelligence / Profile preview

CorePath Laboratories

San Antonio, Texas, United States

Ownership: Private
Employees: ~43
Development stage: Other

Overview

CorePath Laboratories provides commercially available comprehensive diagnostic services for cancer, including molecular genetics, cytogenetics, flow cytometry, immunohistochemistry, FISH, next-generation sequencing, and proprietary early lung cancer blood testing. Clinical data published in collaboration demonstrates reliability of AI-based transcriptomic analysis in diagnostics and supports their role as a pathology leader.

Therapeutic areas: Oncology
Modalities: Diagnostic deviceNext generation sequencingLiquid biopsyPCR-based assayDigital pathology
Industry: Molecular Diagnostics

Partnerships

Genomic Testing Cooperative (NGS technology and AI diagnostics)Cizzle Biotechnology (early lung cancer blood test development)

Beyond the preview

Go deeper on CorePath Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CorePath Laboratories.

Explore the full profile